Data derived Extrapolation Factors for developmental toxicity: A preliminary research case study with perfluorooctanoate (PFOA).

Authors:
Dr. Michael Dourson, PhD, DABT, FATS, FSRA
Dr. Michael Dourson, PhD, DABT, FATS, FSRA
Toxicology Excellence for Risk Assessment
Director of Science
toxicology
Cincinnati, Ohio | United States

Regul Toxicol Pharmacol 2019 Nov 16;108:104446. Epub 2019 Aug 16.

RG York and Associates, LLC, Cincinnati, Ohio, USA.

Guidelines of the United States Environmental Protection Agency (EPA, 1991) and the International Programme on Chemical Safety (IPCS, 2005) suggest two different default positions for dosimetric extrapolation from experimental animals to humans when the dosimetry of the critical effect is not known. The default position of EPA (1991) for developmental toxicity is to use peak concentration (or Cmax) for this dosimetric extrapolation. In contrast, IPCS (2005, page 39) states its default position for dosimetric choice in the absence of data is to use the area under the curve (or AUC). The choice of the appropriate dose metric is important in the development of either a Chemical Specific Adjustment Factor (CSAF) of IPCS (2005) or a Data Derived Extrapolation Factor (DDEF) of EPA (2014). This research shows the derivation of a DDEF for developmental toxicity for perfluorooctanoate (PFOA), a chemical of current interest. Here, identification of the appropriate dosimetric adjustment from a review of developmental effects identified by EPA (2016) is attempted. Although some of these effects appear to be related to Cmax, most appear to be related to the average concentration or its AUC, but only during the critical period of development for a particular effect. A comparison was made of kinetic data from PFOA exposure in mice with newly available and carefully monitored kinetic data in humans after up to 36 weeks of PFOA exposure in a phase 1 clinical trial by Elcombe et al. (2013). Using the average concentration during the various exposure windows of concern, the DDEF for PFOA was determined to be 1.3 or 14. These values are significantly different than comparable extrapolations by several other authorities based on differences in PFOA half-life among species. Although current population exposures to PFOA are generally much lower than both the experimental animal data and the clinical human study, the development of these DDEFs is consistent with current guidelines of both EPA (2014) and IPCS (2005).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yrtph.2019.104446DOI Listing
November 2019
509 Reads
2.031 Impact Factor

Publication Analysis

Top Keywords

ipcs 2005
16
developmental toxicity
12
epa 2014
8
perfluorooctanoate pfoa
8
average concentration
8
default position
8
kinetic data
8
epa 1991
8
derived extrapolation
8
pfoa exposure
8
dosimetric extrapolation
8
data derived
8
pfoa
7
data
6
epa
5
attempted effects
4
epa 2016
4
appear average
4
cmax appear
4
effects appear
4

Similar Publications